NZE · RYM.NZ · NZD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · NZD. Historical prices are not a forecast.
Ryman Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 41.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ryman Healthcare Limited’s forward annual dividend is NZ$0.16 per share, paid semi-annual. The forward yield is 8.82% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ryman Healthcare Limited’s next earnings report is currently expected on Nov 25, 2026, with estimated earnings per share of NZ$0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ryman Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ryman Healthcare Limited, established in Christchurch, New Zealand, in 1984, specializes in the development, ownership, and management of all-encompassing retirement communities for seniors. Operating across both New Zealand and Australia, the company provides a wide array of living and care solutions. These range from independent townhouses and apartments to serviced accommodations, complemented by dedicated care facilities offering residential, hospital, and specialized dementia care, alongside respite and day care services. Each of these integrated villages is equipped with extensive amenities, including indoor heated swimming pools, fitness centers, libraries, dining rooms, internet cafes, bars, retail outlets, movie theaters, bowling greens, and beauty and hairdressing salons. As of May 20, 2022, Ryman Healthcare oversaw 45 retirement villages, encompassing roughly 8,538 independent living units and 4,239 care beds.
Latest available per-share figures in NZD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NZ$482.90M-45.52% vs estimate |
| Q2 2023 | Nov 17, 2022 | NZ$0.24+56.13% vs estimate | NZ$445.90M+3.34% vs estimate |
|---|
| Q4 2022 | May 19, 2022 | NZ$0.28 | NZ$433.20M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NZ$47.66+NZ$0.28 (+0.59%)
Fisher & Paykel Healthcare Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 3.97% below the high.
NZ$6.56+NZ$0.06 (+0.92%)
Summerset Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 48.75% below the high.
NZ$4.65-NZ$0.05 (-1.06%)
AFT Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.12% below the high.
NZ$0.64-NZ$0.01 (-1.54%)
Oceania Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 31.18% below the high.
NZ$0.24NZ$0.00 (0.0%)
Pacific Edge Limited’s quoted price sits in the lower half of its reported 52-week range, 30.88% below the high.
NZ$1.93-NZ$0.01 (-0.26%)
Green Cross Health Limited’s quoted price sits in the upper half of its reported 52-week range, 14.22% below the high.
NZ$0.39NZ$0.00 (0.0%)
Radius Residential Care Limited’s quoted price sits in the lower half of its reported 52-week range, 20.41% below the high.
NZ$0.67NZ$0.00 (0.0%)
Promisia Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 15.19% below the high.
